id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-296683-fjn29oal	Sarode, Sachin C	Oral submucous fibrosis and COVID-19: Perspective on comorbidity	2020-05-21		.txt	text/plain	961	70	54	Novel Corona Virus infection (COVID-19) is a highly infective disease with rapid global spread since January 2020 and was declared as pandemic by World Health Organization. 1 Angiotensin Converting Enzyme 2 (ACE 2), present on the cell surfaces of some important organs, has been identified as target receptor for COVID-19 virus entry into the host cells. 3 In addition, ACE 2 has been reported to be present at various locations in the oral cavity and hence, oral cavity is considered as a potential site for the COVID 19 virus. 8 Thus, the less availability of ACE 2 in the oral cavity might have compromised the binding of COVID 19 virus. The other way round, if OSMF patient is affected with COVID-19, then it may cause further exhaustion of ACE 2. As ACE 2 is the binding site for COVID-19, it may compromise the infectivity of the virus.	./cache/cord-296683-fjn29oal.txt	./txt/cord-296683-fjn29oal.txt